miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity
about
Circulating MicroRNAs as Biomarkers in Biliary Tract CancersHemostatic disorders of the menopausal period: the role of microRNAThe Regulation of Reverse Cholesterol Transport and Cellular Cholesterol Homeostasis by MicroRNAsThe effects of microRNA on the absorption, distribution, metabolism and excretion of drugsBile acid signaling in metabolic disease and drug therapymiR-29b represses intestinal mucosal growth by inhibiting translation of cyclin-dependent kinase 2Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity.MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatmentPharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiRPerilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte.Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33Impaired liver regeneration in Ldlr-/- mice is associated with an altered hepatic profile of cytokines, growth factors, and lipids.MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases.Non-coding RNAs and lipid metabolismmicroRNAs and HDL life cycle.MicroRNAs and lipoproteins: a connection beyond atherosclerosis?Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in micemiR-183 inhibits invasion of gastric cancer by targeting Ezrin.Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506.Recent Advances in Understanding of NASH: MicroRNAs as Both Biochemical Markers and Players.Modulation by miR-29b of intestinal epithelium homoeostasis through the repression of menin translation.MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosisMicroRNA control of high-density lipoprotein metabolism and functionMacrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis.Therapeutic Inhibition of miR-33 Promotes Fatty Acid Oxidation but Does Not Ameliorate Metabolic Dysfunction in Diet-Induced Obesity.Function and clinical potential of microRNAs in hepatocellular carcinoma.MicroRNA Regulation of Atherosclerosis.A big role for small RNAs in HDL homeostasis.miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and EffluxMechanistic Role of MicroRNAs in Coupling Lipid Metabolism and Atherosclerosis.MicroRNAs as biomarkers of hepatotoxicity in a randomized placebo-controlled study of simvastatin and ubiquinol supplementation.Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice.MicroRNAs in metabolic disease.MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.Therapeutic silencing of fat-specific protein 27 improves glycemic control in mouse models of obesity and insulin resistance.MicroRNAs and Cardiovascular Disease.Micro-RNAs and High-Density Lipoprotein Metabolism.How Gene Networks Can Uncover Novel CVD Players.microRNAs in lipoprotein metabolism and cardiometabolic disorders.
P2860
Q26746000-8508261C-B8A2-4576-8704-C63D867EB4ADQ26795566-8F38A724-D6BD-4A57-90C4-32C050E068F5Q26801471-DC67D834-15EF-49F4-B349-1DA3D0C086E4Q26822987-8B054870-7C51-432C-A0AA-540425226140Q28244875-FE4355A4-AC78-4943-B549-8BECC1271B1BQ28505972-354E9FE1-DD8D-48D2-923E-ECAE45A7D65EQ30586189-5E62E40D-AC68-4E7F-ACF2-2E31837ECB8CQ33607587-8CAC1C80-A658-4D47-A0CA-4E8C9D9299C9Q33661920-6600C2D9-7546-4838-8EC1-B8FE08262063Q33923114-5062FD44-B4FA-4E50-B462-965956BEA9ABQ33940346-3C9D475F-EDC8-4472-AB04-37A34BCCC86BQ34093088-0FA5F12F-C207-4D3C-B4A3-E3DBBD817D8BQ34093118-80C9AA4F-5084-4E40-B110-2E7F14F7208BQ34158382-9FB0E55E-4321-4BA5-97B7-A4F88DD184F2Q34248289-0F24D73D-077A-4B22-A576-3A336EB75783Q34321706-13A23FE3-B3A0-43D7-98B3-F6BCD54A02DAQ34342477-2C12A22D-F67A-4E03-8F76-AE96B83E5DD5Q34371214-57FD648C-A701-4EE3-98B5-84900F0BBBB0Q34680467-5F52E4CA-BBE6-495E-A2EA-7400CDB9A656Q34801354-C8734B7D-E6E6-48E0-AF57-BBDC58EE91D7Q34821020-5D153317-D859-48E7-B59D-C18340C16EF2Q34860544-EFD3C405-C981-4D76-BF47-E81BC6DF9C5CQ35008059-353BC1A0-783E-40A3-A138-51678C4A504BQ35200081-1764A575-BCBB-4AA1-8076-920D69F33195Q36083076-0FFE17C6-D8CD-4B4D-A48E-FCA0613CB35AQ36326825-B8C7AA76-CFE5-49F9-A6D8-22992E3BE6E6Q36336198-5575AF2E-D7EF-4CD9-B0F8-4C8566786640Q36602813-C15A8B89-32E0-4755-99A3-1503511F9878Q36754770-AD6AF56F-DF3C-4083-8447-FA05967B8707Q36849588-F1CA6150-DB87-4280-98EC-954C81E85F78Q36912465-EAAD2752-4EAA-4DE5-A87E-224D6AF0F1B9Q37071691-2977FA52-91CE-4FF6-9459-421522298705Q37075782-E20FB1DC-928F-49A6-B5C7-DFDE4041D6A6Q37088373-FFEE08D2-E903-4385-8E17-B345095820EEQ37394060-210E73EB-567B-47C6-9484-97491CD7BEFEQ37585546-D5495262-B989-42F7-A0E6-AFE8B5D72E74Q37593859-77E176F2-E7B8-4CD9-B8F8-C07270068A21Q37650114-7B825309-547A-4F42-80F8-4666BFCBB0E7Q37664007-33150E4F-55F2-48AA-A87D-58F29D0F0410Q37709886-4484F033-7B63-4857-9CEE-DA4658D6C22B
P2860
miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
miR-33 controls the expression ...... nd diet-induced hepatotoxicity
@en
type
label
miR-33 controls the expression ...... nd diet-induced hepatotoxicity
@en
prefLabel
miR-33 controls the expression ...... nd diet-induced hepatotoxicity
@en
P2093
P2860
P921
P356
P1476
miR-33 controls the expression ...... nd diet-induced hepatotoxicity
@en
P2093
Angel Baldán
Carolyn J Albert
David Q-H Wang
Frederick J Suchy
Meenakshisundaram Ananthanarayanan
Ryan M Allen
Tyler J Marquart
P2860
P304
P356
10.1002/EMMM.201201228
P577
2012-07-05T00:00:00Z